Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease
-
By
-
Ana Belén Caminero
-
María Luisa Martínez Ginés
-
Montserrat Gómez Gutiérrez
-
Inmaculada García Castañón
-
May 28, 2026
-
Clinical Scorecard: The Biological and Clinical Spectrum of Multiple Sclerosis: Examining Risk Factors and Initial Disease Stages
At a Glance
| Category | Detail |
|---|
| Condition | Multiple Sclerosis (MS) |
| Key Mechanisms | Genetic susceptibility, environmental exposures, immune-mediated inflammation, neurodegeneration. |
| Target Population | Young adults, pediatric patients, older individuals (late-onset MS). |
| Care Setting | Clinical settings for diagnosis and management of MS. |
Key Highlights
- MS may unfold along a biological continuum before clinical symptoms appear.
- Genetic and environmental factors contribute to MS susceptibility.
- Emerging biomarkers and neuroimaging techniques aid in early detection.
- Asymptomatic individuals may fulfill MS diagnostic criteria under specific circumstances.
- The concept of MS includes biological, clinical, and diagnostic dimensions.
Guideline-Based Recommendations
Diagnosis
- Consider asymptomatic individuals with characteristic radiological and CSF findings for MS diagnosis.
Management
Monitoring & Follow-up
Risks
- Carrying HLA-DRB1*15:01 triples the risk of developing MS.
Patient & Prescribing Data
Individuals at risk of developing MS due to genetic and environmental factors.
No specific treatment insights provided in the source material.
Clinical Best Practices
- Utilize advances in imaging and biomarkers for early detection of MS.
- Recognize the importance of genetic and environmental factors in MS risk assessment.
Related Resources & Content
